Pedro L Moro
Overview
Explore the profile of Pedro L Moro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
96
Citations
1680
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oliveira M, Marquez P, Ennulat C, Blanc P, Welsh K, Nair N, et al.
Drug Saf
. 2024 Dec;
48(3):279-286.
PMID: 39666166
Background: On June 8, 2021, a new 20-valent pneumococcal conjugate vaccine (PCV20, PREVNAR 20, Pfizer, Inc.) was licensed for use in adults aged ≥ 18 years by the US Food...
2.
Hause A, Moro P, Baggs J, Zhang B, Marquez P, Melgar M, et al.
MMWR Morb Mortal Wkly Rep
. 2024 May;
73(21):489-494.
PMID: 38814851
No abstract available.
3.
Strid P, Abara W, Clark E, Moro P, Olson C, Gee J
Obstet Gynecol
. 2024 May;
144(2):283-287.
PMID: 38781590
We identified U.S. reports of postmenopausal bleeding in the VAERS (Vaccine Adverse Event Reporting System) between December 13, 2020, and December 13, 2021. Among 711,224 VAERS reports after coronavirus disease...
4.
Moro P, Scheffey A, Gallego R, Jones J, Hall E, Zhang B, et al.
Pediatrics
. 2024 May;
153(6).
PMID: 38721658
No abstract available.
5.
Duffy J, Myers T, Marquez P, Rouse D, Brown H, Zhang B, et al.
Sex Transm Dis
. 2024 Apr;
51(8):509-515.
PMID: 38647241
Background: In response to the 2022 mpox outbreak in the United States, people with higher potential for exposure to mpox were recommended to receive 2 doses of the JYNNEOS vaccine....
6.
Moro P, Carlock G, Fifadara N, Habenicht T, Zhang B, Strid P, et al.
Vaccine
. 2024 Mar;
42(9):2380-2384.
PMID: 38462432
Background: Pregnant persons are at increased risk of severe COVID-19 illness. Bivalent mRNA COVID-19 vaccination is recommended for everyone, including pregnant persons. However, data are limited on the safety of...
7.
Moro P, Ennulat C, Brown H, Woody G, Zhang B, Marquez P, et al.
Drug Saf
. 2024 Feb;
47(5):487-493.
PMID: 38411838
Introduction: Bivalent mRNA coronavirus disease 2019 (COVID-19) vaccines may be simultaneously administered with other recommended vaccines, including seasonal influenza vaccines. However, few studies have evaluated the safety of co-administration of...
8.
Moro P, Gallego R, Scheffey A, Fleming-Dutra K, Hall E, Zhang B, et al.
Obstet Gynecol
. 2024 Feb;
143(5):704-706.
PMID: 38394669
The GSK and Pfizer respiratory syncytial virus (RSV) vaccines are both indicated for adults aged 60 years and older, but only the Pfizer product is approved for use in pregnancy...
9.
Romanson B, Moro P, Su J, Marquez P, Nair N, Day B, et al.
MMWR Morb Mortal Wkly Rep
. 2023 Aug;
72(31):850-851.
PMID: 37535499
No abstract available.
10.
Moro P, Zhang B, Marquez P, Reich J
J Pediatr
. 2023 Jul;
262:113643.
PMID: 37517652
We assessed the safety of hexavalent vaccine diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, hepatitis b, and haemophilus influenzae b conjugate vaccine in the Vaccine Adverse Event Reporting...